Quantcast

Biogen Idec (NASDAQ:BIIB)

biotech

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

The higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios. With the market currently teetering on ...
Read Full Story »
Bull and Bear

Top Analyst Downgrades and Stocks to Sell: Biogen Idec, Dean Foods, Kinross Gold and More

Investors frequently get to see the analyst upgrades and Buy ratings from Wall Street firms. What investors often do not get to see is when analyst downgrade stocks to sell ...
Read Full Story »
health care

Top Stocks That May Move Big at Jefferies Global Healthcare Conference

Once again, the Wall Street conference calendar is heating up. Next week is the widely attended Jefferies Global Healthcare Conference in New York City. Following the success of last year’s ...
Read Full Story »
pills

Deutsche Bank Firm on Biotech Stocks to Buy

Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — Wednesday: Markets Cannot Shake-off Low Open and Sink to Close

U.S. equity markets opened lower this morning following a weaker-than-expected employment report from ADP and concern that Friday’s report from the Bureau of Labor Statistics will follow the ADP lead ...
Read Full Story »
Stock Split Image

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Biotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many ...
Read Full Story »
Bull and Bear

Top Wall Street Analyst Downgrades: Biogen, LSI, Nuance and More

Investors frequently get to see the analyst upgrades and Buy ratings from Wall Street firms. They often do not get to see when analyst downgrade stocks to sell or to ...
Read Full Story »
Wall St Bull statue

The Big Bull Market Road Map for April

The end of March brought on the last trading of the quarter, with the S&P Index hitting new all-time closing highs in what felt like a very choppy couple of ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — March 28, 2013: Markets Higher, S&P 500 Sets Record (NKE, BIIB, RYAAY, VHS, LULU, XONE, PAYX, SNX, TXI, END, FINL, GME, MOS, BBRY, WGO, CALM, DQ, PF, MTG, S, CLWR, DISH)

U.S. equity markets opened slightly higher this morning even following a larger than expected rise in new claims for jobless benefits in the U.S.  The final revision to fourth quarter ...
Read Full Story »
Bull and Bear

Top 12 Analyst Upgrades and Downgrades (ASTM, ARIA, BIIB, LULU, NKE, RYAAY, UA, UTX, VHS, VFC, MS, GS)

Investors and traders are constantly looking for new ideas that will generate profits. 24/7 Wall St. looks over research calls from all over to find great ideas, from value stocks ...
Read Full Story »
biotech

Another Major MS Approval Keeps Driving Biogen Idec

Shares of Biogen Idec Inc. (NASDAQ: BIIB) did not just do well on Wednesday. The stock hit an all-time high. News hit late in the day that the U.S. Food ...
Read Full Story »
Bull and Bear

13 Must-Read Weekend Stock Stories for Monday

It may be the weekend, and the DJIA hit a new high this last week, but there is no such thing as any rest for the wicked. 24/7 Wall St. ...
Read Full Story »
Bull and Bear

Eleven Must-Read Weekend Stock Stories for Monday

24/7 Wall St. has tracked many stocks on the move in the last week. Now it is the weekend and this can be considered your weekend cheat sheet for the ...
Read Full Story »
rumors

Pharma Merger/Buyout Hunt Continues in Biotech, Valuations Under Focus

The hunt by Big Pharma stocks for smaller drug companies and biotech stocks continues. A report citing "sources" from Dow Jones News has signaled that Bristol-Myers Squibb (NYSE: BMY) has ...
Read Full Story »
biotech

ETF Folly: Biotech ETFs, Nothing but Confusion

24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector performed ...
Read Full Story »